Page 3 - Disease Modifying Drugs and Family Planning in MS
P. 3
CONSENSUS RECOMMENDATIONS ON THE USE OF DMDs
DURING PREGNANCY AND BREASTFEEDING
Need for active treatment of MS during pregnancy
01 02 03
There is a low risk of This information is In general, the current
adverse pregnancy helpful to counsel and contraindications in
outcomes in patients reassure patients who the labelling for current
who became pregnant become pregnant while DMDs should be
while taking most DMDs. taking a DMD who respected.
decide to take their
pregnancy to term.
04 05 06
The group recommends A patient with a low The care of women with
that a patient needs to be level of disease activity high disease activity,
in remission for at least has the option of delaying which usually requires
1 year prior to pregnancy treatment for a year to a high-efficacy DMD,
planning to avoid any complete a pregnancy. involves a trade-off
potential risk of disease between protecting the
reactivation when DMDs patient from relapses
are discontinued. and MS progression
A patient with active MS and minimising the risk
disease requires treatment. of exposure of an
unplanned pregnancy to
treatment.
3
GULF-NONNI-00004
